The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 23, 2025
Filed:
Dec. 11, 2020
Applicants:
Inserm (Institut National DE LA Santé ET DE LA Recherche Médicale), Paris, FR;
Université Paul Sabatier Toulouse Iii, Toulouse, FR;
Icahn School of Medicine AT Mount Sinai, New York, NY (US);
Inventors:
Malik Bisserier, New York, NY (US);
Frank Lezoualc'h, Toulouse, FR;
Lahouaria Hadri, New York, NY (US);
Assignees:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4365 (2006.01); A61K 31/47 (2006.01); A61P 11/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4365 (2013.01); A61K 31/47 (2013.01); A61P 11/00 (2018.01);
Abstract
The present invention relates to the treatment of idiopathic pulmonary fibrosis. Today, there is no cure for IFF. The inventors showed that EPAC1 inhibitors, in particular CE3F4 and AM-001, represent a promising therapeutic strategy for treating patients with pulmonary fibrosis. The present invention thus relates to an EPAC1 inhibitor for use in the treatment and/or prevention of idiopathic pulmonary fibrosis.